SEC Filing Summary: Ecology Coatings, Inc. (Form 8-K)
Business Context and Reporting Period
This Current Report (Form 8-K) was filed on January 23, 2009, by Ecology Coatings, Inc., a Nevada corporation. The filing reports material events occurring on January 21 and January 23, 2009, regarding a financing arrangement with Equity 11, Ltd. Note: The request metadata listed "ABVC BIOPHARMA, INC.", but the filing text explicitly identifies the registrant as Ecology Coatings, Inc.
Key Financial Metrics and Transaction Details
- Capital Raised: $94,000 raised from the purchase of 94 shares of 5% Convertible Preferred Shares at $1,000 per share.
- Security Terms: The Convertible Preferred Shares pay cumulative cash distributions at an initial rate of 5% per annum, subject to Board declaration.
- Warrant Structure: A Second Amendment to the Securities Purchase Agreement establishes a warrant ratio of one-half of a common share for every dollar of Convertible Preferred Shares purchased. The warrant exercise price is $0.75 per share.
- Current Holdings: Following this transaction, Equity 11, Ltd. holds a total of 2,104 Convertible Preferred Shares.
- Debt and Liquidity: The filing text does not provide specific values for total debt, cash flow, or overall liquidity positions.
Material Changes and Agreements
The Company entered into a Second Amendment to Securities Purchase Agreement with Equity 11, Ltd. on January 21, 2009. Key changes include:
- Implementation of the new warrant issuance ratio for future purchases of Convertible Preferred Shares.
- Termination of previously issued Warrant Nos. 3, 4, and 5 held by the Purchaser.
- Execution of an unregistered sale of equity securities on January 23, 2009, relying on the Section 4(2) exemption of the Securities Act.
Outlook, Risks, and Contingencies
The filing does not contain forward-looking guidance, management commentary on future operations, or specific risk factors beyond standard securities law disclosures. The Company notes that the Convertible Preferred Shares and underlying common shares are unregistered and may not be offered or sold in the United States absent registration or an applicable exemption.
Key Facts for Investor Verification
- Verify the total outstanding number of Convertible Preferred Shares and the aggregate potential dilution from the new warrant structure.
- Confirm the Company's current cash position and whether the $94,000 infusion addresses immediate liquidity needs.
- Review the terms of the terminated Warrants (Nos. 3, 4, and 5) to understand the impact of their removal on the Purchaser's total position.
- Check subsequent filings for the declaration of the 5% cumulative cash distributions.